skip to main content

Cluster of Excellence “Controlling Microbes to Fight Infections” (CMFI)

Understanding antibiotic resistance the easy way: CMFI launches Microbe Media Lab
03.11.2026 Understanding antibiotic resistance the easy way: CMFI launches Microbe Media Lab Press Release
Ruth Ley receives IFF Science Award
19.10.2026 Ruth Ley receives IFF Science Award CMFI News
Birgit Schittek receives Händel prize for animal welfare 2026
15.10.2026 Birgit Schittek receives Händel prize for animal welfare 2026 CMFI News
AI and synthetic biology for new antibiotics: KERN project funded
12.10.2026 AI and synthetic biology for new antibiotics: KERN project funded CMFI News
Gut microbes help set the body’s response to vaccination
08.10.2026 Gut microbes help set the body’s response to vaccination Press Release
Dietary fiber does not act alone in the microbiome
06.10.2026 Dietary fiber does not act alone in the microbiome Press Release

Events

Tiny Giants – The Power of Microorganisms
05.09.2026 – 17.05.2027 Tiny Giants – The Power of Microorganisms Exhibition More
Decoding nucleosome remodeling: molecular structures and single-molecule dynamics
26.11.2026 Decoding nucleosome remodeling: molecular structures and single-molecule dynamics 12:30 pm 3:30 pm Joint Microbiology Colloquium Sebastian Deindl More
EMBL Conference: Unlocking the Functional Diversity of Gut Microbiomes
08.12.2026 – 10.12.2026 EMBL Conference: Unlocking the Functional Diversity of Gut Microbiomes Conference Lisa Maier More
ASOs for microbes: Programmable RNA antibiotics for selective targeting of bacteria and phages
17.12.2026 ASOs for microbes: Programmable RNA antibiotics for selective targeting of bacteria and phages 12:30 pm 3:30 pm Joint Microbiology Colloquium Jörg Vogel More
Tba
28.01.2027 Tba 12:30 pm 3:30 pm Joint Microbiology Colloquium Jörn Piel More
CMFI 2027 – 5th International Conference
17.02.2027 – 19.02.2027 CMFI 2027 – 5th International Conference Symposium More

About the CMFI

The surfaces of the human body host colonies of microorganisms, known as microbiomes. Along with bacteria which have a positive effect on human health, microbiomes contain potentially life-threatening pathogens. In the past, broad-spectrum antibiotics have often been used to tackle them. Nowadays it is known that this not only promotes resistance to antibiotics – in many cases it also damages the microbiome as a whole. 

 

CMFI researchers aim to develop new strategies to control microbial mechanisms and fight infections.

The Cluster of Excellence CMFI brings together roughly 150 researchers from different disciplines such as infection biology, immunology, bioinformatics, pharmaceutical biology, antibiotics research, molecular and medical microbiology, biotechnology, environmental biology, systems biology, chemistry, and medical history and ethics. Their common goal is to elucidate the mechanisms of interaction between beneficial and harmful bacteria and the host in order to develop novel targeted therapeutic and anti-infective treatments.

The CMFI is one of 70 Clusters of Excellence funded by German federal and state governments as part of the Excellence Strategy to sustainably strengthen Germany as a center of science, improve its international competitiveness and make cutting-edge research at German universities visible. The CMFI has been funded since 2019 and is in its second funding phase from 2026, which runs until 2032. In addition to the University of Tübingen, the Max Planck Institute for Biology and the University Hospital Tübingen are involved in the CMFI.

More about the Research